Archito T. Tamayo

1.5k total citations
34 papers, 1.2k citations indexed

About

Archito T. Tamayo is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Archito T. Tamayo has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Archito T. Tamayo's work include Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (10 papers) and NF-κB Signaling Pathways (9 papers). Archito T. Tamayo is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Chronic Lymphocytic Leukemia Research (10 papers) and NF-κB Signaling Pathways (9 papers). Archito T. Tamayo collaborates with scholars based in United States and China. Archito T. Tamayo's co-authors include R. Ford, Lan V. Pham, Linda C. Yoshimura, Piao Lo, Yen-Chiu Lin-Lee, Jan A. Burger, Antonina V. Kurtova, Lingchen Fu, Changping Li and J. Jack Lee and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Archito T. Tamayo

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Archito T. Tamayo United States 16 631 413 412 393 250 34 1.2k
Lan V. Pham United States 23 822 1.3× 583 1.4× 556 1.3× 580 1.5× 307 1.2× 57 1.7k
Virginia Snell United States 14 542 0.9× 387 0.9× 391 0.9× 249 0.6× 189 0.8× 19 1.1k
Jana Šmardová Czechia 14 460 0.7× 250 0.6× 431 1.0× 296 0.8× 287 1.1× 57 1.0k
Lorraine Tracey United States 15 580 0.9× 216 0.5× 321 0.8× 181 0.5× 266 1.1× 20 1.1k
Linda C. Yoshimura United States 10 356 0.6× 392 0.9× 247 0.6× 264 0.7× 210 0.8× 17 837
Georgios Z. Rassidakis United States 17 489 0.8× 234 0.6× 414 1.0× 375 1.0× 96 0.4× 34 1.0k
Laurence Cooke United States 19 532 0.8× 215 0.5× 505 1.2× 213 0.5× 105 0.4× 39 1.1k
Lixin Rui United States 19 724 1.1× 986 2.4× 374 0.9× 290 0.7× 221 0.9× 37 1.9k
Bryan Ciccarelli United States 13 530 0.8× 302 0.7× 264 0.6× 276 0.7× 121 0.5× 34 1.1k
Šárka Pavlová Czechia 15 443 0.7× 176 0.4× 258 0.6× 190 0.5× 161 0.6× 42 854

Countries citing papers authored by Archito T. Tamayo

Since Specialization
Citations

This map shows the geographic impact of Archito T. Tamayo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archito T. Tamayo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archito T. Tamayo more than expected).

Fields of papers citing papers by Archito T. Tamayo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Archito T. Tamayo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archito T. Tamayo. The network helps show where Archito T. Tamayo may publish in the future.

Co-authorship network of co-authors of Archito T. Tamayo

This figure shows the co-authorship network connecting the top 25 collaborators of Archito T. Tamayo. A scholar is included among the top collaborators of Archito T. Tamayo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Archito T. Tamayo. Archito T. Tamayo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pham, Lan V., Jerry Bryant, Richard Mendez, et al.. (2016). Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma. Oncotarget. 7(49). 80599–80611. 25 indexed citations
2.
Pham, Lan V., Gary Lu, Archito T. Tamayo, et al.. (2015). Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC. Journal of Hematology & Oncology. 8(1). 121–121. 9 indexed citations
3.
Pham, Lan V., Archito T. Tamayo, Gary Lu, et al.. (2014). The Tumor Microenvironment in Mantle Cell Lymphoma (MCL): Novel Targets to Overcome Chemo-Resistance in MCL. Blood. 124(21). 494–494. 1 indexed citations
4.
5.
Zhang, Liang, Lan V. Pham, Kate J. Newberry, et al.. (2013). In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome. Molecular Cancer Therapeutics. 12(11). 2494–2504. 22 indexed citations
6.
7.
Ou, Zhishuo, Lan V. Pham, Liang Zhang, et al.. (2013). Targeting BCR Activated STAT3 By Ibrutinib In Mantle Cell Lymphoma. Blood. 122(21). 3079–3079. 5 indexed citations
8.
Pham, Lan V., Archito T. Tamayo, Zhishuo Ou, et al.. (2013). The Role Of Mir-155 In Controlling Key Growth and Survival Pathways In ABC-Subtype DLBCL. Blood. 122(21). 1274–1274. 1 indexed citations
9.
Lyu, Mi-Ae, Lan V. Pham, Bokyung Sung, et al.. (2012). The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma. Biochemical Pharmacology. 84(4). 451–458. 4 indexed citations
10.
Pham, Lan V., Archito T. Tamayo, J. Jack Lee, et al.. (2012). Biological Significance of the Immumoproteasome Subunits Mecl-1 and LMP-2 in Diffuse Large B-Cell Lymphoma.. Blood. 120(21). 2717–2717. 1 indexed citations
11.
Wang, Michael, Archito T. Tamayo, Sharon Shacham, et al.. (2012). Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma. Experimental Hematology. 41(1). 67–78.e4. 82 indexed citations
12.
13.
Pham, Lan V., Archito T. Tamayo, Changping Li, et al.. (2010). Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo : Therapeutic Implications. Molecular Cancer Therapeutics. 9(7). 2026–2036. 46 indexed citations
14.
Ford, R., Long Shen, Yen Chiu Lin-Lee, et al.. (2007). Development of a murine model for blastoid variant mantle-cell lymphoma. Blood. 109(11). 4899–4906. 25 indexed citations
15.
Pham, Lan V., Haijun Zhou, Yen-Chiu Lin-Lee, et al.. (2007). Nuclear Tumor Necrosis Factor Receptor-associated Factor 6 in Lymphoid Cells Negatively Regulates c-Myb-mediated Transactivation through Small Ubiquitin-related Modifier-1 Modification. Journal of Biological Chemistry. 283(8). 5081–5089. 24 indexed citations
16.
Lin-Lee, Yen-Chiu, Lan V. Pham, Archito T. Tamayo, et al.. (2006). Nuclear Localization in the Biology of the CD40 Receptor in Normal and Neoplastic Human B Lymphocytes. Journal of Biological Chemistry. 281(27). 18878–18887. 43 indexed citations
17.
Pham, Lan V., Archito T. Tamayo, Linda C. Yoshimura, et al.. (2006). Bortezomib Synergizes with a Novel Jak2 Inhibitor, WP-1130, To Inhibit Cell Growth and Induce Apoptosis in “Classic” and “Blastoid-Variant” Mantle Cell Lymphoma.. Blood. 108(11). 2512–2512. 1 indexed citations
18.
Pham, Lan V., Yen-Chiu Lin-Lee, Haijun Zhou, et al.. (2006). TRAF6 and C-myb Show Novel Functions in the Nucleus of Lymphoma B Cells.. Blood. 108(11). 2376–2376. 1 indexed citations
19.
Pham, Lan V., Archito T. Tamayo, Linda C. Yoshimura, Piao Lo, & R. Ford. (2003). Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis. The Journal of Immunology. 171(1). 88–95. 266 indexed citations
20.
Pham, Lan V., Archito T. Tamayo, Linda C. Yoshimura, et al.. (2002). A CD40 Signalosome Anchored in Lipid Rafts Leads to Constitutive Activation of NF-κB and Autonomous Cell Growth in B Cell Lymphomas. Immunity. 16(1). 37–50. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan V. Pham Breakdown of academic impact, for papers by Virginia Snell Breakdown of academic impact, for papers by Jana Šmardová Breakdown of academic impact, for papers by Lorraine Tracey Breakdown of academic impact, for papers by Linda C. Yoshimura Breakdown of academic impact, for papers by Georgios Z. Rassidakis Breakdown of academic impact, for papers by Laurence Cooke Breakdown of academic impact, for papers by Lixin Rui Breakdown of academic impact, for papers by Bryan Ciccarelli Breakdown of academic impact, for papers by Šárka Pavlová
Rankless by CCL
2026